|
Abbott rises after FDA approves Xience V stent (AP) |
|
|
Shares of Abbott Laboratories rose Thursday after regulators approved its drug-coated Xience V stent for sale. The Food and Drug Administration approved the stent late Wednesday, and Abbott expects it to take between 25 percent and 30 percent of the U.S. drug-coated stent market over the next 12 months.
Read more at: . |
Dow Jones
7552.29 
1316.12 